Research Article
ADAMTS-5 Decreases in Coronary Arteries and Plasma from Patients with Coronary Artery Disease
Table 2
Information of clinical characteristics and laboratory data in the NCAD group and the CAD group.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are expressed as median (interquartile range) or the number (percentage) for category variables. Glu: fasting glucose; SBP: systolic blood pressure; DBP: diastolic blood pressure; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TC: total cholesterol; TG: total triglycerides; CRP: C-reactive protein; ADAMTS-5: a disintegrin and metalloproteinase with thrombospondin type 1 motif-5; MMP-2: matrix metalloproteinase-2; MMP-9: matrix metalloproteinase-9; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium channel blockers. |